Chinese regulators announced Friday they plan to invest in the consolidation of the domestic infant milk formula industry in efforts to strengthen local competition after various foreign companies were fined for price-fixing.
According to reports, the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Finance and the China Food and Drug Administration announced late last week that it will pump funds into the industry and provide tax breaks to companies for merging. The regulators aim to create 10 infant formula competitors that own 65 percent of the market.
The plans are part of the nation’s efforts to improve the infant milk industry after six international competitors were fined $109 million for anticompetitive behavior, including price-fixing.
More than 40 foreign firms hold a presence in the Chinese market, reports say.
Full content: Forbes
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI